HCPLive

Neurology - Page 2
The MD Magazine Neurology - Page 2 specialty page provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

Conditions

Conferences

Latest CME

Latest Headlines

Nanostructure Saline RNS60 has Potential Benefits for Myelin Maintenance, Repair
RNS60, a charge-stabilized nanostructure, shows potential as a beneficial therapy for demyelinating conditions, such as multiple sclerosis (MS), according to the results of a recent study.
Good research has shown that diabetes is linked to heightened risk for brain atrophy, white matter abnormalities, and cognitive impairment. It's a risk factor for dementia, especially if the diabetes is classified as type 2.
Men over the age of 50 who have human immunodeficiency virus (HIV) and who are adherent to an antiretroviral therapy (ART) regimen are at risk for cognitive decline, according to the results of a recent study.
It has been many years since Howard Schatz was a practicing physician and while he said the retina specialty has changed he has also seen the field of photography change as digital passes the age of film.
It was supposed to be just a one year sabbatical for Howard Schatz to take a break from his work as a retina specialist and enjoy what had become a growing hobby of photography. More than two decades later Schatz said he misses some parts of practice but is greatly enjoying what has become a second career.
β€œOn the basis of evidence currently available, IL-1 RA is an attractive candidate drug for clinical trial.” Interleukin-1 is an anti-inflammatory protein typically used to treat rheumatoid arthritis.
There are differences in the tissue sodium signal and the fluid-attenuated sodium signal in the brain lesions of patients with acute multiple sclerosis (MS) and those with chronic MS, according to a recent study.
Among 968 patients, initial stability was no indicator of ongoing stability: only 34% of them remained in the therapeutic window at least 80% of the time.
Quantitative magnetic resonance imaging (qMRI) may be a good tool for assessing disease status among patients with secondary progressive multiple sclerosis (SPMS), according to the results of a study published in the journal PLOS One

Most Popular in Neurology - Page 2

Recent Published Journal

@MDMagazine

$vacMongoViewPlus$ $vAR$